Most people are into lists and I am no exception. So, without further ado, here is a list of the top 20 drugs by 2007 sales.
Also, because I’m a nice guy, I’ve published the top 82 compounds with loads of other information that wouldn’t fit in the post (e.g.; 2005 and 2006 sales, CAGR [...]
(From PRNewswire via PhRMA Report)
Pharmaceutical R&D spending increased nearly $3B from 2006 to a
record $58.8B for 2007. Comparatively, only ~60 countries have a
larger nominal GDP. The report illustrates big pharma’s willingness to
dump metric buttloads of money on a failing system that produces fewer
and fewer drug candidates while at the same time laying [...]
Like the FDA needs more bad press. The beleaguered drug watchdog
has taken hits aplenty over the last few years for more reason that can
be counted. The etiology of which, stem mostly from the lack of
sufficient funding from congress and an increasing workload. A study
published today in the NEJM illustrates what happens when [...]
Hat tip to seekingalpha
As far as market cap is concerned, Gilead (GILD) at least
fleetingly topped Amgen (AMGN) as the world’s second highest valued
biotech company. Amgen has taken some hits recently over their anemia
drug franchise and yesterday were overtaken in market capitalization
by a company with a third their revenue.
I made a long Amgen call nearly a [...]
Recent Comments